New Venturetec reported earnings results for the year ended September 30, 2015. For the year, the company reported a gain of USD 14,998,112 or USD 3.00 per share, compared to a loss of USD 20,639,722 or USD 4.13 per share in the fiscal year 2013/14. The main reason for the gain was the increase of the quoted share price of Osiris Therapeutics from USD 12.59 per share to USD 18.47 per share.

The gain was reduced by the decrease of the valuation of the private company mPortal from USD 0.50 per share to USD 0.31 per share and the loss of the investment in Reverb Network in the reporting period. The details on the valuation of the portfolio companies are described in the annual report.